4888.T JPX
Stella Pharma Corporation
1W: -0.5%
1M: +18.3%
3M: +37.0%
YTD: +23.8%
1Y: +5.7%
3Y: +32.3%
5Y: -25.9%
¥452.00 ($2.87)
+26.00 (+6.10%)
Weekly Expected Move ±6.2%
¥373
¥400
¥426
¥452
¥479
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#12
of 50
Biotechnology
Technical Signal Map
11 Bullish
0 Neutral
2 Bearish
4888.T
$15B
Stella Pharma Corporation
BULLISH
+78
2160.T
$215B
GNI Group Ltd.
BULLISH
+100
219A.T
$60B
Heartseed, Inc.
BULLISH
+91
7777.T
$55B
3-D Matrix, Ltd.
BULLISH
+87
4579.T
$15B
RaQualia Pharma Inc.
BULLISH
+87
4588.T
$177B
Oncolys BioPharma Inc.
BULLISH
+65
504A.T
$28B
Innovacell Inc.
BULLISH
+65
4587.T
$146B
PeptiDream Inc.
BULLISH
+59
7774.T
$35B
Japan Tissue Engineering Co., Ltd.
BULLISH
+33
4894.T
$51B
Cuorips Inc.
LEAN BULL
+28
4565.T
$116B
Nxera Pharma Co., Ltd.
LEAN BULL
+15
4592.T
$75B
SanBio Company Limited
LEAN BEAR
-15
4593.T
$40B
Healios K.K.
LEAN BEAR
-17
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| 4888.T Stella Pharma Corporation | $15B | -18.0 | -8.2 | -54.5 | -247.7 | 242.6 | 3 | BULLISH | 5.7 |
| 2160.T GNI Group Ltd. | $215B | -34.0 | -14.5 | -2.1 | 2.2 | 9.9 | 4 | BULLISH | 14.0 |
| 219A.T Heartseed, Inc. | $60B | -91.8 | 7.8 | 8.1 | — | — | 5 | BULLISH | -24.3 |
| 7777.T 3-D Matrix, Ltd. | $55B | 14.1 | 92.2 | 29.3 | 50.9 | 57.0 | 5 | BULLISH | 82.6 |
| 4579.T RaQualia Pharma Inc. | $15B | 68.3 | 2.3 | 2.3 | -36.9 | 20.6 | 8 | BULLISH | -2.7 |
| 4588.T Oncolys BioPharma Inc. | $177B | -117.7 | -157.1 | -397.4 | -1757.1 | -9.0 | 1 | BULLISH | 852.2 |
| 504A.T Innovacell Inc. | $28B | — | — | — | — | — | — | BULLISH | — |
| 4587.T PeptiDream Inc. | $146B | -37.5 | -7.1 | -9.5 | -25.7 | 0.6 | 5 | BULLISH | -32.3 |
| 7774.T Japan Tissue Engineering Co., Ltd. | $35B | -77.9 | -4.0 | -7.1 | 6.8 | 2.4 | 3 | BULLISH | 56.0 |
| 4894.T Cuorips Inc. | $51B | -48.7 | -13.9 | -50.9 | -20505.0 | 1222.1 | 2 | LEAN BULL | -4.1 |
| 4565.T Nxera Pharma Co., Ltd. | $116B | -14.3 | -11.9 | -1.7 | -2.6 | 7.1 | 4 | LEAN BULL | 36.5 |
| 4592.T SanBio Company Limited | $75B | -19.9 | -50.0 | 1249.8 | — | — | 4 | LEAN BEAR | -64.5 |
| 4593.T Healios K.K. | $40B | 58.1 | 4.1 | -132.0 | 17028.6 | -47.3 | 4 | LEAN BEAR | -54.4 |
| 4888.T Stella Pharma Corporation | $15B | -18.0 | -8.2 | -54.5 | -247.7 | 242.6 | 3 | BULLISH | 5.7 |
| 2160.T GNI Group Ltd. | $215B | -34.0 | -14.5 | -2.1 | 2.2 | 9.9 | 4 | BULLISH | 14.0 |
| 219A.T Heartseed, Inc. | $60B | -91.8 | 7.8 | 8.1 | — | — | 5 | BULLISH | -24.3 |
| 7777.T 3-D Matrix, Ltd. | $55B | 14.1 | 92.2 | 29.3 | 50.9 | 57.0 | 5 | BULLISH | 82.6 |
| 4579.T RaQualia Pharma Inc. | $15B | 68.3 | 2.3 | 2.3 | -36.9 | 20.6 | 8 | BULLISH | -2.7 |
| 4588.T Oncolys BioPharma Inc. | $177B | -117.7 | -157.1 | -397.4 | -1757.1 | -9.0 | 1 | BULLISH | 852.2 |
| 504A.T Innovacell Inc. | $28B | — | — | — | — | — | — | BULLISH | — |
| 4587.T PeptiDream Inc. | $146B | -37.5 | -7.1 | -9.5 | -25.7 | 0.6 | 5 | BULLISH | -32.3 |
| 7774.T Japan Tissue Engineering Co., Ltd. | $35B | -77.9 | -4.0 | -7.1 | 6.8 | 2.4 | 3 | BULLISH | 56.0 |
| 4894.T Cuorips Inc. | $51B | -48.7 | -13.9 | -50.9 | -20505.0 | 1222.1 | 2 | LEAN BULL | -4.1 |
| 4565.T Nxera Pharma Co., Ltd. | $116B | -14.3 | -11.9 | -1.7 | -2.6 | 7.1 | 4 | LEAN BULL | 36.5 |
| 4592.T SanBio Company Limited | $75B | -19.9 | -50.0 | 1249.8 | — | — | 4 | LEAN BEAR | -64.5 |
| 4593.T Healios K.K. | $40B | 58.1 | 4.1 | -132.0 | 17028.6 | -47.3 | 4 | LEAN BEAR | -54.4 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
4888.T vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F